FR2809401B1 - Produits radiopharmaceutiques utiles pour le marquage selectif des lymphocytes et leur preparation - Google Patents

Produits radiopharmaceutiques utiles pour le marquage selectif des lymphocytes et leur preparation

Info

Publication number
FR2809401B1
FR2809401B1 FR0006549A FR0006549A FR2809401B1 FR 2809401 B1 FR2809401 B1 FR 2809401B1 FR 0006549 A FR0006549 A FR 0006549A FR 0006549 A FR0006549 A FR 0006549A FR 2809401 B1 FR2809401 B1 FR 2809401B1
Authority
FR
France
Prior art keywords
lymphocytes
preparation
radiopharmaceutical products
products useful
selective marking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0006549A
Other languages
English (en)
Other versions
FR2809401A1 (fr
Inventor
Roberto Pasqualini
Emmanuel Bellande
Nicolas Noiret
Alain Roucoux
Henri Patin
Franck Mevellec
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CIS Bio International SA
Original Assignee
CIS Bio International SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CIS Bio International SA filed Critical CIS Bio International SA
Priority to FR0006549A priority Critical patent/FR2809401B1/fr
Priority to US09/584,108 priority patent/US6469146B1/en
Priority to PT01934220T priority patent/PT1283842E/pt
Priority to AT01934220T priority patent/ATE256690T1/de
Priority to DK01934220T priority patent/DK1283842T3/da
Priority to DE60101574T priority patent/DE60101574T2/de
Priority to JP2001586301A priority patent/JP2003534348A/ja
Priority to TR2004/00533T priority patent/TR200400533T4/xx
Priority to ES01934220T priority patent/ES2213115T3/es
Priority to EP01934220A priority patent/EP1283842B1/fr
Priority to AU2001260519A priority patent/AU2001260519A1/en
Priority to PCT/IB2001/000825 priority patent/WO2001090114A1/fr
Publication of FR2809401A1 publication Critical patent/FR2809401A1/fr
Priority to NO20025473A priority patent/NO20025473L/no
Application granted granted Critical
Publication of FR2809401B1 publication Critical patent/FR2809401B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1203—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules in a form not provided for by groups A61K51/1206 - A61K51/1296, e.g. cells, cell fragments, viruses, virus capsides, ghosts, red blood cells, viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR0006549A 2000-05-23 2000-05-23 Produits radiopharmaceutiques utiles pour le marquage selectif des lymphocytes et leur preparation Expired - Fee Related FR2809401B1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR0006549A FR2809401B1 (fr) 2000-05-23 2000-05-23 Produits radiopharmaceutiques utiles pour le marquage selectif des lymphocytes et leur preparation
US09/584,108 US6469146B1 (en) 2000-05-23 2000-05-31 Radiopharmaceutical products suitable for the selective labeling of lymphocytes, and their preparation
EP01934220A EP1283842B1 (fr) 2000-05-23 2001-05-14 Produits radiopharmaceutiques permettant le marquage selectif des lymphocytes, et preparation de ces derniers
DK01934220T DK1283842T3 (da) 2000-05-23 2001-05-14 Egnede radiofarmaceutiske produkter til selektiv mærkning af lymfocytter og fremstilling heraf
DE60101574T DE60101574T2 (de) 2000-05-23 2001-05-14 Radiopharmazeutische verbindungen geeignet zur selektiven kennzeichnung von lymphocyten und ihre herstellung
JP2001586301A JP2003534348A (ja) 2000-05-23 2001-05-14 白血球の選択的標識に適した放射性医薬生成物、及びそれらの製造
PT01934220T PT1283842E (pt) 2000-05-23 2001-05-14 Produtos radiofarmaceuticos adequados para a marcacao selectiva de linfocitos e sua preparacao
ES01934220T ES2213115T3 (es) 2000-05-23 2001-05-14 Productos radiofarmaceuticos adecuados para la marcacion selectiva de linfocitos, y su preparacion.
AT01934220T ATE256690T1 (de) 2000-05-23 2001-05-14 Radiopharmazeutische verbindungen geeignet zur selektiven kennzeichnung von lymphocyten und ihre herstellung
AU2001260519A AU2001260519A1 (en) 2000-05-23 2001-05-14 Radiopharmaceutical products suitable for the selective labeling of lymphocytes,and their preparation
PCT/IB2001/000825 WO2001090114A1 (fr) 2000-05-23 2001-05-14 Produits radiopharmaceutiques permettant le marquage selectif des lymphocytes, et preparation de ces derniers
TR2004/00533T TR200400533T4 (tr) 2000-05-23 2001-05-14 Lenfositlerin seçmeli işaretlenmesine uygun farmasötik ürünler ve bunların hazırlanışı
NO20025473A NO20025473L (no) 2000-05-23 2002-11-15 Radiofarmasöytiske produkter egnet for selektiv merking av lymfocytter, ogfremstilling derav

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0006549A FR2809401B1 (fr) 2000-05-23 2000-05-23 Produits radiopharmaceutiques utiles pour le marquage selectif des lymphocytes et leur preparation
US09/584,108 US6469146B1 (en) 2000-05-23 2000-05-31 Radiopharmaceutical products suitable for the selective labeling of lymphocytes, and their preparation

Publications (2)

Publication Number Publication Date
FR2809401A1 FR2809401A1 (fr) 2001-11-30
FR2809401B1 true FR2809401B1 (fr) 2004-01-02

Family

ID=26212417

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0006549A Expired - Fee Related FR2809401B1 (fr) 2000-05-23 2000-05-23 Produits radiopharmaceutiques utiles pour le marquage selectif des lymphocytes et leur preparation

Country Status (13)

Country Link
US (1) US6469146B1 (fr)
EP (1) EP1283842B1 (fr)
JP (1) JP2003534348A (fr)
AT (1) ATE256690T1 (fr)
AU (1) AU2001260519A1 (fr)
DE (1) DE60101574T2 (fr)
DK (1) DK1283842T3 (fr)
ES (1) ES2213115T3 (fr)
FR (1) FR2809401B1 (fr)
NO (1) NO20025473L (fr)
PT (1) PT1283842E (fr)
TR (1) TR200400533T4 (fr)
WO (1) WO2001090114A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2832408B1 (fr) * 2001-11-20 2005-07-15 Schering Ag Complexes de technetium ou de rhenium, produits radiopharmaceutiques les contenant et leur preparation
EP2125802A4 (fr) * 2007-02-16 2014-08-20 Debiopharm Int Sa Sels, promédicaments et polymorphes d'inhibiteurs de fab 1
FR2956325B1 (fr) 2010-02-18 2013-03-15 Enscr Radiomarquage stable a dose therapeurique au rhenium-188, et automatisation de celui-ci, en particulier pour le traitement du cancer du foie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2698272B1 (fr) 1992-11-20 1994-12-30 Cis Bio Int Procédé de marquage cellulaire au moyen de complexes nitruro-bis (dithiocarbamato)Tc-99m et trousse pour la mise en Óoeuvre de ce procédé.

Also Published As

Publication number Publication date
FR2809401A1 (fr) 2001-11-30
AU2001260519A1 (en) 2001-12-03
ES2213115T3 (es) 2004-08-16
NO20025473L (no) 2003-01-21
DK1283842T3 (da) 2004-04-13
EP1283842B1 (fr) 2003-12-17
DE60101574D1 (de) 2004-01-29
DE60101574T2 (de) 2004-09-16
US6469146B1 (en) 2002-10-22
EP1283842A1 (fr) 2003-02-19
ATE256690T1 (de) 2004-01-15
NO20025473D0 (no) 2002-11-15
PT1283842E (pt) 2004-04-30
WO2001090114A1 (fr) 2001-11-29
JP2003534348A (ja) 2003-11-18
TR200400533T4 (tr) 2004-04-21

Similar Documents

Publication Publication Date Title
FR2848850B1 (fr) Nouvelles compositions de particules magnetiques recouvertes de derives gem-bisphosphonates.
BG106771A (en) Heterocyclic substituted pyrazolones
DE69002248D1 (de) 1,2-cyclohexylaminoarylamide zu verwendung als analgetika.
DE602004021472D1 (en) Pyrimiidinverbindungen
NL980012I2 (nl) Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen.
ES2192520T3 (es) Composicion farmaceutica.
TW200716518A (en) Acetylene derivatives
TWI268278B (en) 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses
MXPA04000210A (es) Conjugados quelantes mejorados.
DE60309027D1 (de) Stabilisiertes Antitranspirantmittel Sojaprodukte enthaltend
FR2589763B1 (fr) Procede de production d'une poudre d'alliage contenant des metaux de terres rares.
MXPA04003986A (es) Carboxamidas hetero-biciclicas n-azabiciclico sustituidas como agonistas nachr.
SE0200919D0 (sv) Chemical compounds
EP1104761A4 (fr) Reactifs de marquage fluorescents
MXPA01008347A (es) Compuestos quimicos.
FR2809401B1 (fr) Produits radiopharmaceutiques utiles pour le marquage selectif des lymphocytes et leur preparation
DE60215408D1 (de) Verfahren zur Herstellung von Trialkylmetallverbindungen der Gruppe Va Metalle
TW200505415A (en) Composition for improving immunity of animals
AR012990A1 (es) Compuestos de benzo(5,6) cicloheptapiridina, composiciones farmaceuticas que los contienen, y el uso de dichos compuestos como inhibidores de laproteina farnesil transferasa.
EA200401338A1 (ru) Агенты контроля пенообразования
FR2806726B1 (fr) Procede de preparation de la (2s,3r,4s)-4-hydroxyisoleucine et de ses analogues
DE502004009136D1 (de) NEUE HETEROARYLSUBSTITUIERTE ACETONDERIVATE ALS HEMMSTOFFE DER PHOSPHOLIPASE A sb 2 /sb
MXPA04003200A (es) Nuevos compuestos de isoquinolina, un proceso para su preparacion y composiciones farmaceuticas que los contienen.
BR0311590A (pt) Agonistas de brs-3 não-peptìdicos
NO842345L (no) Heksahydropyrrolo(2,1-a)isoquinolin-derivater.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20080131